Skip to content

Clinical study of Amalaki Rasayan in ARMD.

A randomized open labelled controlled clinical study of efficacy of Amalaki Rasayan in Vataj Timir with special reference to age related macular degeneration(Dry). - Not applicable

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/063199
Enrollment
220
Registered
2024-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H353- Degeneration of macula and posterior pole

Interventions

None listed

Sponsors

Dr Sarika Govindrao Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients selected as per diagnostic criteria of Dry ARMD

Exclusion criteria

Exclusion criteria: patients age below 50 years and above 80 years suffering from acute infectious disease of eye and general systemic illness.

Design outcomes

Primary

MeasureTime frame
MRCC stage score grade from 3 to 1 will be expectedTimepoint: 90 Days

Secondary

MeasureTime frame
1)To understand the pathology of disease through Ayurvedic point of view. 2)To record the adverse effect of the treatment if any.Timepoint: During first two weeks.

Countries

India

Contacts

Public ContactDrsarika Govind Rao Patil

Government Ayurved college Nanded

Dr.khan_na@yahoo.com9325607099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026